CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
2.530
-0.030 (-1.17%)
At close: Sep 8, 2026, 4:00 PM EDT
2.564
+0.004 (0.15%)
Pre-market: Sep 9, 2026, 7:56 AM EDT
CervoMed Market Cap
CervoMed has a market cap or net worth of $38.25 million as of September 8, 2026. Its market cap has decreased by -60.67% in one year.
Market Cap
38.25M
Enterprise Value
13.31M
1-Year Change
-60.67%
Ranking
Category
Stock Price
$2.53
ChartMarket Cap Chart
Since August 17, 2023, CervoMed's market cap has decreased from $43.26M to $38.25M, a decrease of -11.58%. That is a compound annual growth rate of -3.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 38.25M | -47.67% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 43.99M |
| Metagenomi Therapeutics | 43.82M |
| Mereo BioPharma Group | 40.66M |
| Karyopharm Therapeutics | 39.01M |
| Actinium Pharmaceuticals | 38.67M |
| NextCure | 38.54M |
| Filana Therapeutics | 38.51M |
| Lite Strategy | 37.43M |